Monograph Capital Holdings Advisors reported a 1.9% stake in UroGen Pharma URGN · 838,615 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 1.9%
Last report: No earlier report
Shares held: 838,615 sh
Class: Ordinary Shares, par value NIS 0.01 per share
Stock: UroGen Pharma URGN
Holder: Monograph Capital Holdings Advisors
Event date: 25/06/05
Filed: 25/06/09

1.9% stake · below 5%

UroGen Pharma trades, last 26 weeks

What else happened in UroGen Pharma around then

Filed or reported within 30 days of the trade day · 25/05/06~25/07/05

Monograph Capital Holdings Advisors's other 5% stake reports

No other trades yet.